Key Financial Data Of Group

Delta-Fly Pharma, Inc. - Filing #7591826

Concept As at
2022-06-30
2022-04-01 to
2022-06-30
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2021-06-30
2021-04-01 to
2021-06-30
Key financial data of group
Business results of group
Ordinary profit (loss)
-307,853,000 JPY
-964,064,000 JPY
-306,159,000 JPY
Net assets
924,458,000 JPY
1,233,161,000 JPY
1,893,561,000 JPY
Total assets
1,040,582,000 JPY
1,324,352,000 JPY
2,025,895,000 JPY
Basic earnings (loss) per share
-56.96
-178.58
-56.76
Diluted earnings per share
Equity-to-asset ratio
0.888 xbrli:pure
0.931 xbrli:pure
0.934 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.